Palak patel, Rvaf cv

American Board of Ophthalmology – Board Certified 2024-present

The Retina Institute in St. Louis – St. Louis, MO 2023-2025
Vitreoretinal Surgery Fellow

Rush University Medical Center – Chicago, IL 2019-2023
Department of Ophthalmology – Chief Resident 2022-2023

Rush Medical College – Chicago, IL 2015-2019
Doctor of Medicine Candidate, Class of 2019

Northwestern University – Evanston, IL 2011-2015
Bachelor of Arts, Neurobiology

ASRS 2024: Top 10 Poster Award Recipient Jul 2024

Beem-Fisher Research Award – Third Place Recipient May 2022
• Analysis of PVD and Development of Complications Using a Large Database of Retina Specialists
Illinois Society for the Prevention of Blindness Grant Recipient
• May 2018: Epidemiology, Incidence, and Outcomes in Ocular Trauma at an Inner City County Hospital – Awarded $1,000 for statistical support
• May 2021: Analysis of PVD and Development of Complications Using a Large Database of Retina Specialists – Awarded $1,000 for statistical support

Rush Emergency Medicine Exemplary Consultant Award Jan 2021

Rush University Summer Dean’s Research Fellowship Jun 2016 – Aug 2016
• Sex and Gender Health: A Pilot study of a Sex and Gender Specific Medical Curriculum for Healthcare Providers and Students.

Patel, P; “Updates in toxicity and retinal health”, The Retina Institute of St. Louis – Topical Conference, July 2024
Patel, P; “Updates in AMD and Degenerative Maculopathies”, The Retina Institute of St. Louis – Topical Conference, March 2025
Patel, P; Dang, S; “Pneumatic Retinopexy: A Case of an Almost Happy Accident”; Women in Retina Case Conference Aug 2024, virtual format
Patel, P; Jalalizadeh, R; Smith, BT; “Choroidal Thickness as a Clinical Marker in Differentiating Peripheral Retinoschisis and Retinal Detachments”
• ASRS 2024 Poster Session, Stockholm, Sweden – Top 10 Poster award
• Vit-Buckle Society March 2025, Austin, TX
Patel, P; Tom, E; Thomas, M; Dang, S; Durrani, A; “Comparing post-intravitreal injection pain scores using Lotemax SM, Prolensa, and preservative-free artificial tears over a 24-hour time period: A randomized, placebo-controlled trial – The Retina Society 2023 Poster Session, New York, NY
Patel, P; Raiji V; Michael, R; German, O; Thomas, C; Gushchin, A; “Epidemiology, Incidence, and Outcomes in Ocular Traumas at an Inner City County Hospital.”. Rush University Department of Ophthalmology Resident and Alumni Day 2023, Chicago, IL.
Patel, P; Minkowski, J; Dajani, O; MacCumber, M;, Boucher, N; “Analysis of PVD and Development of Complications Using a Large Database of Retina Specialists”
• ARVO Annual Meeting May 2021. Oral presentation – Virtual.
• Rush University Medical Center, Department of Ophthalmology, Alumni Day Symposium June 2022.
Patel, P; Shepherd, EA; Chaturvedi, V; “Scleral Buckle Removal: Long-term Patient Outcomes”
• ARVO Annual Meeting May 2022. Poster Presentation – In-person.
• ASRS Annual Meeting July 2022. Poster Presentation – In-person.
Patel, P., MacCumber M, “A Stick and a Wick: Posterior Vitreous Wick Syndrome” – Rabb Retina Study Club, Chicago IL, June 2022
Patel, P; “Ahmed Valve Exposure” – Glaucoma Study Club April 2021
Patel, P; Pittner, A; Merrill, P; “Undiagnosed Ocular Syphilis Treated With Immunosuppressive Therapy”. Case presentation at Rabb Retina Study Club, Chicago, IL. March 2018
Patel, P; Arif, S; Casanova, R; Cheon, J; Volgman, A; Aggarwal, N; “Sex and Gender Health: A Pilot study of a Sex and Gender Specific Medical Curriculum for Healthcare Providers and Students”. Poster presentation, Women Physician’s Congress 2018, Washington DC.
Grand Rounds Presentations:
• Patel, P; “Ring of Fire: VZV Retinitis”; Uveitis Grand Rounds – Department of Ophthalmology, Rush University Medical Center, Nov 2021.
• Patel, P; “Ophthalmology and Albinism”, Pediatric Grand Rounds – Department of Ophthalmology, Rush University Medical Center, May 2022.
• Patel, P; “Sonic Hedgehog Inhibitors and Basal Cell Carcinoma”, Oculoplastics Grand Rounds – Department of Ophthalmology, Rush University Medical Center, Aug 2021.
• Patel, P; “Persistent Fetal Vasculature”, Pediatric Grand Rounds – Department of Ophthalmology, Rush University Medical Center, May 2021.
• Patel, P.; “Frost in the Forecast: CMV retinitis”, Uveitis Grand Rounds – Department of Ophthalmology, Rush University Medical Center, Mar 2021.

Patel P, Heo JY, Shepherd EA, Chaturvedi V. “Scleral Buckle Removal: Long-Term Patient Outcomes”. Ophthalmology Retina. S2468-6530(23)00363-9. July 2023.

Patel P, Minkowski J, Dajani O, Weber J, Boucher N, MacCumber MW. “Analysis of Posterior Vitreous Detachment and Development of Complications Using a Large Database of Retina Specialists”. Ophthalmology Retina. 7(3):203-214. March 2023.

Rubenstein, J; Patel, P; “4.7 Allergic Conjunctivitis”. Yanoff & Duker: Ophthalmology 6e. book chapter, Elselvier. 2022.

Patel, P; Merrill, PT; “Frost in the forecast: A case of CMV Retinitis.” Doximity., https://www.rush.edu/sites/default/files/cmv-retinitis-case-study.pdf. October 2020

Chen, O; Patel, P; Minkowski, J; & Mizen, T; “A Rare Case of Bilateral Multifocal Metastatic Lesion in the Extraocular Muscles from Pancreatic Cancer”. Doximity – Rush. https://www.rush.edu/sites/default/files/rare-case-bilateral-multifocal-metastatic-lesion.pdf. July 2020.

Patel, P; Pittner AC; Merrill, PT; “Undiagnosed Ocular Syphilis Treated With Immunosuppressive Therapy.” Journal of VitreoRetinal Diseases, 3(4), 242–245. July 2019.

Patel, P; Pittner, A; Al-Zubidi, N; & Lee, NG; “Orbital apex syndrome.” EyeWiki. https://eyewiki.aao.org/Orbital_Apex_Syndrome#
Patel, P; Schaps, M; “Adverse Childhood Experiences Policy Briefs.” Distributed at the 2015 Midwest Regional Summit on Adverse Childhood Experiences. Brochure/briefs available at http://www.hmprg.org/Events/2015ACEsSummit

2024 – Present Lugano: Phase 3, Multicenter, Prospective, Randomized, Double-Masked,
Parallel-Group Study of EYP-1901, a Tyrosine Kinase Inhibitor
(TKI), Compared to Aflibercept in Subjects with Wet AMD

2024 – Present Burgundy: A Phase 1, Open-Label, Multicenter Study of the Port Delivery System (PDS) with Dutacizumab (Dutafab) Compared to Lucentis (Ranibizumab) in Patients with Wet Age-Related Macular Degeneration

2024 – Present Jannsen extension: Long-term Extension Study for Participants with Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) in JNJ-81201887 Parent Clinical Studies

2023 – Present Oculis Stage 2: A Phase 2/3 Double-masked, Randomized, 2 stage, Multicenter Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects with Diabetic Macular Edema

2023-Present SOL-1 and SOL-R: A Phase 3, Multicenter, Double-Masked, Randomized, Parallel-Group Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (axitinib implant) in Subjects with Neovascular Age-Related Macular Degeneration

2023-Present Discover: Phase 1/2a Study of the Safety and Bioactivity of AXT107 Injected Suprachoroidally in Subjects with Neovascular Age-Related Macular Degeneration

2022-Present Olix: A Phase 1, Multicenter, Open-Label, Single- and Multi-Dose, Dose-Escalating Clinical Study to Evaluate the Safety and Tolerability of OLX10212 Administered by Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration

2024-Present BP41670 Burgundy Part 3: A Three-Part, Phase I Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7250284 Following Intravitreal Administration of Multiple Ascending Doses and Continuous Delivery From The Port Delivery in Patients with Neovascular Age-Related Macular Degeneration

2023-Present BP44241 Rivol1: A Phase 1b, Multicenter, Randomized, Double-Masked, Active Comparator-controlled Study to Investigate the Biological Activity, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7200394 in Participants with Macular Edema Secodary to Central Retinal Vein Occlusion

2023-Present Atmosphere: A Randomized, Partially Masked, Controlled, Phase 2b/3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants with nAMD

2023-Present ONL: A Phase 2, Randomized, Sham-Controlled, Single-Masked, Dose-
Ranging, Multi-Center Study to Assess the Safety and Efficacy of
Intravitreal ONL1204 Ophthalmic Solution in Subjects with Macula-off
Rhegmatogenous Retinal Detachment

2023-Present Rezolute: A Randomized, Double-Masked, Placebo-Controlled, Parallel-Arm Study
to Evaluate the Efficacy and Safety of RZ402 in Participants with Diabetic
Macular Edema (DME)

2022-Present AMEND: A Phase 2, Double-Masked, Randomized, Placebo controlled, Dose-Response Study Assessing The Safety And Efficacy Of Qa102 In Subjects With Dry Age-Related Macular Degeneration (AMD)

2022-Present Olix: A Phase 1, Multicenter, Open-Label, Single- and Multi-Dose, Dose-Escalating Clinical Study to Evaluate the Safety and Tolerability of OLX10212 Administered by Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)

2022-Present Davio 2: A Phase 2, Multicenter, Prospective, Randomized, Double-Masked,
Parallel Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI),
Compared to Aflibercept in Subjects with Wet AMD

2022-Present Janssen: A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment
of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

2022-Present Tejas: A Two Stage Phase 2 Study: Stage 1: Single Subcutaneous Dose Open-label Assessment of Safety and Pharmacodynamic Response to D-4517.2 (hydroxyl dendrimer VEGFR tyrosine kinase inhibitor) in subjects with Neovascular (wet) Age-Related Macular Degeneration (AMD) or subjects with Diabetic Macular Edema (DME). Stage 2: Visual Examiner-Masked, Randomized Active, Sham and Placebo Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of a Subcutaneously Administered D-4517.2 to Subjects with Neovascular (wet) Age-Related Macular Degeneration

2021-Present VILLA: A Phase 2, Double-Masked, Randomized, Placebo-Controlled, Dose-Response Study Assessing The Safety And Efficacy Of Qa102 In Subjects With Dry Age-Related Macular Degeneration (AMD)

2021-Present COAST: A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with Aflibercept Alone, in Participants with Neovascular Age-related Macular Degeneration (nAMD)

2020-Present NHOR: Natural History, Observation, and Registry of Macular Telangiectasia Type 2

Access Community Health Network – Chicago, IL Apr 2013 – Aug 2013
Patient Centered Medical Home Intern
• Worked extensively on the process of patient empanelment for clinics in underserved communities throughout the Chicago land area.

Health and Medicine Policy Research Group – Chicago IL Feb 2015 – Apr 2015
Policy Intern
• Developed brochure and policy briefs for distribution at the 2015 Midwest Regional Summit on Adverse Childhood Experiences

LEAN Process Improvement Committee Jul 2020 – Jul 2023
• Monthly meetings involving representative resident physicians, clinical operations staff, ophthalmic technicians, and administrative staff to address clinical concerns and processes.

20/20 Free Eye Clinic at Community Health Center (Volunteer) Sep 2016 – Jul 2023
• Work to provide low-income adults with access to focused eye exams, visual impairment screenings, and referrals to low-cost eye centers
• Provide teaching to medical student volunteers on ophthalmologic examination and disease.

Gujarati – fluent
Spanish – clinically competent